with the development of diseases, and the molecules or molecular signature of EVs may 48 serve as non-invasive diagnostic biomarkers of diseases. Moreover, the unique biological 49 activity of EVs has displayed potential benefit for the correction of cellular dysfunction 50 and in turn, the therapy of diseases (21). EVs have also been considered to be ideal 
II. Extracellular vesicles

58
Three main types of EVs have been described, including apoptotic bodies, microvesicles 59 or microparticles, and exosomes (62, 66 In a clinical study, it was observed that the mRNA level of CD2AP, a podocyte marker, osteoprotegerin, an inflammatory marker, was shown to be increased in uEVs of CKD 150 patients (6). These data suggest that EVs may reflect renal fibrosis as well as the 151 inflammatory state within the renal microenvironment of CKD patients.
152
In obstructive nephropathy, uEVs may be useful for evaluating the risk of those genes were associated with fatty acid metabolism, inflammation, matrix-receptor 288 interaction, and cell adhesion(17) .
289
Of note, EVs are not always beneficial to kidneys as they can also aggravate the 290 progression of diseases. This notion is supported by that observation that in renal I/R,
291
EVs from proximal tubular cells may induce fibroblast activation and expansion to 292 promote interstitial fibrosis and tissue deterioration(52). 
